Advertisement

Topics

AMORCHEM L.P. Company Profile

18:29 EDT 20th April 2018 | BioPortfolio

AmorChem (www.amorchem.com) is an early-stage, venture capital fund located in Montreal focused on creating promising life science companies from technologies originating primarily from Quebec-based universities and research centres. Launched in 2011, the AmorChem fund model combines access to financial resources with a virtual incubator structure that enables the rapid development and commercialization of its technologies. The first fund (41.2M$) has built a portfolio of 24 technologies and successfully transacted two pharma exits as well as spun-out five companies. The attractiveness of this seed fund model and the role it plays in the life science ecosystem were highlighted in September 2017 with the launch of the AmorChem II fund of 44.2M$.


News Articles [9 Associated News Articles listed on BioPortfolio]

AmorChem raises C$44.2M towards second fund

AmorChem raises C$44.2M toward second fund

AMORCHEM ANNOUNCES AN INVESTMENT BY FONDACTION IN ITS FUND

AmorChem is pleased to announce the addition of Fondaction to the limited partners of the AmorChem II Fund L.P. The fund initially closed on September 19, 2017, having raised capi...

Dr. Nancy Braverman: Champion of the AmorChem KNOCK OUT!

The Contenders of the fourth AmorChem KNOCK OUTTM Event valiantly climbed into the ring and duked it out against a panel of Heavyweight Champions for a chance of winning a coveted...

LSP’s big cost-saving fund

Why LPs clamored to back €280 million LSP Health Economics Fund 2. Plus: Montreal VC AmorChem’s new fund; and Atlas and OrbiMed’s Kyndred spirits.

What You Need to Know About Corbin Therapeutics

Corbin Therapeutics, headquartered in Montreal, Quebec, was spun out of venture capital company AmorChem.

AmorChem Announces the Composition of Its Scientific Advisory Committee

With its second fund recently closed, AmorChem is proud to announce the composition of its scientific advisory committee. AmorChem selected these highly qualified individuals beca...

SemaThera Announces a $2MUS Financing and a Licensing Deal for China and Japan

SemaThera Inc announces today the closing of a $2MUS co-investment from Senju Pharmaceutical Co., Ltd. and AmorChem L.P. for the development of its lead candidate, ST-102, in prep...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

AMORCHEM L.P.

AmorChem (www.amorchem.com) is an early-stage, venture capital fund located in Montreal focused on creating promising life science companies from technologies originating p...

AmorChem

More Information about "AMORCHEM L.P." on BioPortfolio

We have published hundreds of AMORCHEM L.P. news stories on BioPortfolio along with dozens of AMORCHEM L.P. Clinical Trials and PubMed Articles about AMORCHEM L.P. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AMORCHEM L.P. Companies in our database. You can also find out about relevant AMORCHEM L.P. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...


Corporate Database Quicklinks



Searches Linking to this Company Record